FdaApplication

ANDA 219401

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASCENT PHARMACEUTICALS INC
application_typeANDA
approval_date2025-12-18

Products (2)

ProductActive ingredientStrengthDosage form
BUPRENORPHINE HYDROCHLORIDEBUPRENORPHINE HYDROCHLORIDEEQ 2MG BASETABLET;SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDEBUPRENORPHINE HYDROCHLORIDEEQ 8MG BASETABLET;SUBLINGUAL

2 products